Diabetic Nephropathies
Research News and Information

Monday, November 23, 2009

The podocyte in diabetic kidney disease.

12 Oct 2009 Approaching epidemic levels, diabetic kidney disease (DKD) is now the leading cause of end-stage renal disease (ESRD). Microalbuminuria is an early clinical marker of DKD that results from damage to the glomerular filtration barrier at the level of ... Read more...

Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications.

29 Sep 2009 Diabetic hepatosclerosis (DH) is a recently described form of diabetic microangiopathy with hepatic sinusoidal fibrosis and basement membrane deposition without cirrhosis. The objective was to investigate the frequency of DH and its correlation with ... Read more...

Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria.

15 Sep 2009 The Aliskiren in the Evaluation of Proteinuria in Diabetes (AVOID) trial demonstrated that adding aliskiren, an oral direct renin inhibitor, at a dosage of 300 mg/d to the highest approved dosage of losartan and optimal antihypertensive therapy ... Read more...

Latest indexed articles for 'Diabetic Nephropathies'

These are the very latest articles for this heading:

• The podocyte in diabetic kidney disease. 12 Oct 2009
• Renal and retinal effects of enalapril and losartan in type 1 diabetes. 29 Sep 2009
• Renal and retinal effects of enalapril and losartan in type 1 diabetes. 29 Sep 2009
• Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. 29 Sep 2009
• Quiz page October 2009. Tetramine poisoning. Neurologic symptoms in a dialysis patient after ingesting seafood. 29 Sep 2009
• Diabetic microangiopathy in the liver: an autopsy study of incidence and association with other diabetic complications. 29 Sep 2009
• Rosiglitazone and pioglitazone. Beware macular oedema. 20 Sep 2009
• Cost-effectiveness of aliskiren in type 2 diabetes, hypertension, and albuminuria. 15 Sep 2009
• Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. 7 Sep 2009
• Adenosine mediates transforming growth factor-beta 1 release in kidney glomeruli of diabetic rats. 4 Sep 2009
• Is CCR5-Delta32 mutation associated with diabetic nephropathy in type 2 diabetes? 30 Aug 2009
• The -174GG interleukin-6 genotype is protective from retinopathy and nephropathy in juvenile onset type 1 diabetes mellitus. 30 Aug 2009
• Inhibition of p300 and nuclear factor-kappaB by curcumin and its role in diabetic nephropathy. 30 Aug 2009
• Impact of comprehensive diabetes specialty care in the management of older adults with stage 3 or 4 nephropathy. 30 Aug 2009
• Ottawa rules, OK? Rules are different in diabetes. 30 Aug 2009
• Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy. 30 Aug 2009
• Long-term effects of rosiglitazone on the progressive decline in renal function in patients with type 2 diabetes. 24 Aug 2009
• MafA-deficient and beta cell-specific MafK-overexpressing hybrid transgenic mice develop human-like severe diabetic nephropathy. 24 Aug 2009
• [Acute abdominal pain in a 70-year-old patient on hemodialysis] 23 Aug 2009
• Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. 10 Aug 2009

See a longer list of these articles.

Technical information about 'Diabetic Nephropathies'

Definition: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Descriptor UI: D003928

Alternative terms: Diabetic Nephropathies; Nephropathies, Diabetic; Nephropathy, Diabetic; Diabetic Nephropathy; Diabetic Kidney Disease; Diabetic Kidney Diseases; Kidney Disease, Diabetic; Kidney Diseases, Diabetic; Diabetic Glomerulosclerosis; Kimmelstiel-Wilson Syndrome; Kimmelstiel Wilson Syndrome; Syndrome, Kimmelstiel-Wilson; Kimmelstiel-Wilson Disease; Kimmelstiel Wilson Disease; Nodular Glomerulosclerosis; Glomerulosclerosis, Nodular; Glomerulosclerosis, Diabetic; Intracapillary Glomerulosclerosis;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C12.777.419.192; C13.351.968.419.192; C19.246.099.875;

Online Note: use DIABETIC NEPHROPATHIES to search KIMMELSTIEL-WILSON SYNDROME 1966-76

History Note: 65(64); KIMMELSTIEL-WILSON SYNDROME was heading 1963-76

Technical Notes: coord IM with specific kidney dis (IM); do not confuse with DIABETES INSIPIDUS, NEPHROGENIC, a form of diabetes insipidus